-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 HpcDZAEwhfx+fneOSZEi8TSGygD7LiTBkOP7jiLO7CuYD2FaM2GeZf61979/qJ9x
 +/FsqXv9vKvvAfzgD6fRng==

<SEC-DOCUMENT>0001193125-07-060599.txt : 20070321
<SEC-HEADER>0001193125-07-060599.hdr.sgml : 20070321
<ACCEPTANCE-DATETIME>20070321160928
ACCESSION NUMBER:		0001193125-07-060599
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20070316
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20070321
DATE AS OF CHANGE:		20070321

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NATURAL ALTERNATIVES INTERNATIONAL INC
		CENTRAL INDEX KEY:			0000787253
		STANDARD INDUSTRIAL CLASSIFICATION:	MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
		IRS NUMBER:				841007839
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-15701
		FILM NUMBER:		07709286

	BUSINESS ADDRESS:	
		STREET 1:		1185 LINDA VISTA DR
		CITY:			SAN MARCOS
		STATE:			CA
		ZIP:			92069
		BUSINESS PHONE:		6197447340

	MAIL ADDRESS:	
		STREET 1:		1185 LINDA VISTA DRIVE
		CITY:			SAN MARCOS
		STATE:			CA
		ZIP:			92069

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AMERICAN ACQUISITIONS INC
		DATE OF NAME CHANGE:	19860929
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML><HEAD>
<TITLE>Form 8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
<HR SIZE="3" NOSHADE COLOR="#000000" ALIGN="left"> <P STYLE="margin-top:3px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="5"><B>UNITED STATES </B></FONT></P> <P
STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="5"><B>SECURITIES AND EXCHANGE COMMISSION </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman"
SIZE="3"><B>Washington, D.C. 20549 </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><HR WIDTH="17%" SIZE="1" NOSHADE COLOR="#000000"> <P STYLE="margin-top:14px;margin-bottom:0px" ALIGN="center"><FONT
FACE="Times New Roman" SIZE="5"><B>FORM 8-K </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><HR WIDTH="17%" SIZE="1" NOSHADE COLOR="#000000"> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT
FACE="Times New Roman" SIZE="3"><B>CURRENT REPORT </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="3"><B>pursuant to Section&nbsp;13 or 15(d) of the Securities Exchange Act of 1934
</B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>DATE OF REPORT </B>(DATE OF EARLIEST EVENT REPORTED):<B> MARCH&nbsp;16, 2007 </B></FONT></P> <P
STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>000-15701 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(Commission file number)
</B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><HR WIDTH="17%" SIZE="1" NOSHADE COLOR="#000000"> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="6"><B>NATURAL
ALTERNATIVES INTERNATIONAL, INC. </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(Exact name of registrant as specified in its charter) </B></FONT></P> <P
STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><HR WIDTH="17%" SIZE="1" NOSHADE COLOR="#000000"> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>Delaware</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>84-1007839</B></FONT></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(State of incorporation)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(IRS Employer Identification No.)</B></FONT></TD></TR>
</TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" ALIGN="center">

<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="48%"></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>1185 Linda Vista Drive</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
FACE="Times New Roman" SIZE="2"><B>San Marcos, California 92078</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>(760) 744-7340</B></FONT></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(Address of principal executive offices)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT FACE="Times New Roman" SIZE="1"><B>(Registrant&#146;s telephone number)</B></FONT></TD></TR>
</TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><HR WIDTH="17%" SIZE="1" NOSHADE COLOR="#000000"> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT FACE="Times New Roman"
SIZE="2">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: </FONT></P> <P
STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </FONT></TD></TR></TABLE> <P
STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </FONT></TD></TR></TABLE> <P
STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"></FONT><FONT FACE="WINGDINGS" SIZE="2" COLOR="#000000">&#168;</FONT><FONT FACE="Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </FONT></TD></TR></TABLE> <P
STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P><HR SIZE="3" NOSHADE COLOR="#000000" ALIGN="left">

<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"><B>Item&nbsp;8.01</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2"><B>Other Events. </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">On March&nbsp;16, 2007, Natural Alternatives
International, Inc. (NAI) issued a press release announcing the receipt of an additional Swiss pharmaceutical license by its subsidiary, Natural Alternatives International Europe, S.A., and an update to its third quarter guidance. A copy of the
press release is filed as Exhibit 99.1 to this report and incorporated herein by reference. </FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2"><B>Item&nbsp;9.01.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2"><B>Financial Statements and Exhibits. </B></FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2">(d)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2"><U>Exhibits</U>. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT FACE="Times New Roman" SIZE="2">99.1</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Press release dated March&nbsp;16, 2007 of NAI. </FONT></TD></TR></TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>SIGNATURES </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT FACE="Times New Roman"
SIZE="2">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </FONT></P> <P
STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0">

<TR>
<TD WIDTH="43%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="43%"></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="3"><FONT FACE="Times New Roman" SIZE="2"><B>Natural Alternatives International, Inc.</B></FONT></TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT FACE="Times New Roman" SIZE="2">Date: March&nbsp;21, 2007</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT FACE="Times New Roman" SIZE="2">By:</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-bottom:1px;border-bottom:1px solid #000000"><FONT FACE="Times New Roman" SIZE="2">/s/ John Reaves</FONT></P></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT FACE="Times New Roman" SIZE="2">John Reaves</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT FACE="Times New Roman" SIZE="2">Chief Financial Officer</FONT></TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>dex991.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<HTML><HEAD>
<TITLE>Press Release</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT FACE="Times New Roman" SIZE="2"><B>Exhibit 99.1 </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center">

<IMG SRC="g43479logo.jpg" ALT="LOGO"> </P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>Natural Alternatives International, Inc. </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"
ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>Receives Additional Swiss Pharmaceutical License and </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT FACE="Times New Roman" SIZE="2"><B>Updates Third Quarter
Guidance </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2"><B>SAN MARCOS, CALIF,</B> March&nbsp;16, 2007 /PRNewswire/ &#151;Natural Alternatives International, Inc. (&#147;NAI&#148;) (Nasdaq-GM:
NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, today announced that the Swissmedic Authority of Bern, Switzerland has granted to NAI&#146;s subsidiary, Natural Alternatives International Europe, S.A.,
(&#147;NAIE&#148;), a second pharmaceutical license. This additional license allows NAIE to manufacture, import and export pharmaceuticals for sale both in Switzerland and internationally and will remain valid until January of 2009. </FONT></P> <P
STYLE="margin-top:12px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">Dr.&nbsp;Fausto Petrini, Managing Director of NAIE stated, &#147;NAIE, operating in Lugano, Switzerland, recently completed expansion of its manufacturing facility to
include powder filling capabilities. Obtaining this additional pharmaceutical licensure certifies that our expanded operations conform to current Good Manufacturing Practices. We anticipate this licensure and our new capabilities will further
improve our ability to develop relationships with new customers.&#148; </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">NAI Chairman of the Board and CEO, Mark A. Le Doux, stated, &#147;In many countries
around the world the manufacture of dietary supplements requires medicinal licensure. This provides assurance to consumers that they will receive high quality products. Achieving this milestone of receiving pharmaceutical licensure from the Swiss
Federal government exemplifies the leadership and dedication of our teams in Lugano, Switzerland and the United States and their commitment to providing our customers with the highest quality manufacturing expertise.&#148; </FONT></P> <P
STYLE="margin-top:12px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">NAI President Randell Weaver added, &#147;Due to the timing of customer orders, we anticipate revenue in the third quarter of fiscal 2007 </FONT>
</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" COLOR="#999999" WIDTH="100%" ALIGN="CENTER">
 <P STYLE="margin-top:0px;margin-bottom:0px">
<FONT FACE="Times New Roman" SIZE="2">will be in line to slightly lower than revenue from the third quarter of the prior year. The timing of customer orders combined with third quarter
investments in regulatory compliance and improvements in customer service may result in lower profitability than previously anticipated.&#148; </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">NAI,
headquartered in San Marcos, California, is a leading formulator, manufacturer and marketer of nutritional supplements that provides strategic partnering services to its customers. Our comprehensive partnership approach offers a wide range of
innovative nutritional products and services to our clients including: scientific research, clinical studies, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, marketing management and
support, packaging and delivery system design, regulatory review and international product registration assistance. For more information about NAI, please see our website at <U>http://www.nai-online.com</U>. </FONT></P> <P
STYLE="margin-top:12px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">This press release contains forward-looking statements within the meaning of Section&nbsp;21E of the Securities Exchange Act of 1934 that are not historical facts and
information. These statements represent our intentions, expectations and beliefs concerning future events, including, among other things, expectations and beliefs with respect to our future revenue and profits, the impact upon future financial and
operating results from the receipt by NAIE of a pharmaceutical license and the investment in its facilities, and our ability to develop relationships with new customers. We wish to caution readers that these statements involve risks and
uncertainties that could cause actual results and outcomes for future periods to differ materially from any forward-looking statement or views expressed herein. Our financial performance and the forward-looking statements contained herein are
further qualified by other risks including those set forth from time to time in the documents filed by us with the Securities and Exchange Commission, including our most recent Quarterly Report on Form 10-Q and Annual Report on Form 10-K.
</FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">SOURCE &#150; Natural Alternatives International, Inc. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT FACE="Times New Roman"
SIZE="2">CONTACT &#150; John R. Reaves, Chief Financial Officer, Natural Alternatives International, Inc., </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT FACE="Times New Roman" SIZE="2">760-736-7700 or info@nai-online.com. </FONT></P>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g43479logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g43479logo.jpg
M_]C_X``02D9)1@`!`@``9`!D``#_[``11'5C:WD``0`$````9```_^X`#D%D
M;V)E`&3``````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$"`0$"
M`@(!`@(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#_\``$0@`D`![`P$1``(1`0,1`?_$`,,```(#``,!`0$`````
M```````(!@<)`00%`P(*`0`"`@(#`0``````````````!P8(!0D"`P0!$```
M!@$#`P(#`P<+!`,````!`@,$!08'`!$2(1,(,11!(A51,A9AD4(C,Q<)<8%2
M)#1TM#:V=SBQP6)4-748$0`"`0,#`@0#!`4'"`@'`0`!`@,1!`4`$@8A!S%!
M$PA1(A1A<3(5@4)28B.1L7(S4Q8)H<%SLR0U%S>"0S1UM39W.-'APF.#="48
M_]H`#`,!``(1`Q$`/P#^_#1HT:-&C1HT:-&J4\C<2ESK@[).)PD',4ZN%>.W
MBI)H\58*L9Z,=M9RNN3.T2**I-TYV,;BMQ*(F1Y!L.^VOJMM-=2+B><_NWR.
MTS>T.D$M64C<"C`HXH>A.QFI]M-8CTSS"_B<UZC_`(8B,74_)$[CHLO5[A9[
M;&F@W#R:JIW$1+R$:@2=9KS$.$NQ5%HJ5LF+ED":FX&,(!W%(R:UU8K(<"[/
M761^LGO9[2VN]LD4<3;P$DHRJQV$*^TC<-QVO4>`U*_![^)[G._O\OQ_D71F
M3EQC!W8X=ZRQTBYE%WUBBG+%>,7K[N6;USW%3FH$LD[(Y<((D3)&*;'4'8-#
MQ@`4\]>#N+V=XYC(K"7BERP6\$;`SD*!&P8,'"F2DJ/Z:E5)J9!T&KOL7\7J
MD-7TRK5\33LG!5ZIOK6Y)8;/#5RTV1!I&#((I4^#;)3K601ECAV(Q99XW!^X
M_5B5$/GU\$)\SJ.VG8G(O%&+V^C2YEG$8V1O)'&2VTF5R4(*_BD`1MB]:MX:
M][*/\2E&9PE;KCA2GVNLV&+<V=BC,Y+K;$\3"JT>"=3MH0EV$19%RMY)5RBV
MBFA#N2\G4@14H*`D*1_@CZ]=>;"]HFM^106'(KB":U<1DI;R'<_K.$C*EHQ5
M:%I&(7\*%>E=P1?`?\17^)[DW'=;R(;`N,U*1.Q`6)*7<.GKV?C8Z2*8["*F
MF[US4CKSK(H=Q4J+0H"F8I"@<P"8>9CC!H3UTR.3=J>SN(RDN+_,[L9*.3TR
M@`",R_B9"!)1#X"K>-2:#H-$_P"&S4\MV6'OOE9FFP2DS8_(IM5']7:2C8T,
M[B:+`I2I(1F^K($[,$H0C[]2B!U52D$>ZJH(@(<)".B#RTJ>[E]@[2>VX3Q^
M)([3%-(LA4[@TSE=Y$GBX^7J:`$^`&M0-=6DWHT:-&C1HT:-&C1HT:-&C1HT
M:-&C1HT:-+%G/Q(PYGJ6C+C98%*+R;6V3MO4\CQ*1$YZ&<*MSI,E7R)A*RLS
M*+7,"R+*0*NU!0-^'4=<E<KT'AJ8\;YSG^,P/86DI?#S,#+`Q^1P#4T/C&6'
M0NA5J>>L7_(/P7R3%VI[=,J1OD=FAI)D>4*^67&=_L-<CLIXI3)]3@J[<JWA
MN:1RK8G##Z>HT:,GC-6!8"]4`O`BI^7<L@\!0:L%Q;N1B)K)<?A7Q./D0B:&
M.X@21K:Y_"\D4ETAMHP=P9G5A,^P5J5&JX;^/?BZCX\^85_E\"4^L2J$KC^B
MX_K%:2LS#\!T^5QC1*M4HNUMIXK8DW+5.=*X4F4.*Z/U9-R!0$PCO]W,6`KK
M+/RGF3<IP.,@R<\T!2>:>20QGUI5N)I)6C*5V+(FT1'H?3*5Z:]6:\-8#,%K
M.QQ-A3+U7C;!)Q-ARNA@FZ72CX!RS/4YN"U<NC.K9*E8#"UG@#2ZZ:JX*$5F
M3N"I*MR&(DJ8IO('4]?M\M=-OS^YP-EZN;R-C--$C1VQO(HIKVV24TDB,ENK
MW<;[`0*$1!=P8U(!UBQ5X'UARZK.0?)-\OF;)4$^BINN-[+VG$1131J:"L7#
M<$%#(6I>$>IBLDX>@N#58XD;"")$MNHR'P7H-)#-]R[M4FQ?$5&/Q$BLDACJ
M&FW$[GZ]8PX-"J;=P`+_`#%M:&%*4A2D(4I"$`"D(4`*4I0#8"E*'0I0#T#7
M7I6$DFIZDZYT:^:-&C1HT:-&C1HT:-&C1HT:-&C1HT:^*[ENU3[KIP@V2WV[
MCA9-!/<?0.:IB%W_`)]>:ZO+.QB]:]ECAAK^)V5!_*Q`USCCDE;;$K,WP`)/
M^37X;/&;TICLW;5V0AN!SM7"+@I#;`/$QD3G`IMAWV'KMKA9Y''Y%#)CYX9X
MU-"8W5P#XT)4FAIY'7V2&:$TF1D)^((_GUG?Y+W2VW7(TQAYD^-%5:"/CJ%5
MB"OU8-A?+3E-A;9:.4N5L0.+B#H]/@:-)*K,D$@<2LDJR(5RW*4P*9!0`*Z:
MO$,?88[$QYZ1=][*)W#;0[0QVS1*WI1GH\TKS1@.3MCC$A*/440K-WC>SP1X
M[>6>,%IYA,N;O.XCMJCR+AI."CS1LQ96,.@X81KZQV-T#=,[04CJ`^$5ER'/
MTY=.P,2P/V:9G'>6OR7E6#S"Q-&MM'<Q49U=MRQER&81QBO6H&SH"!Y:O:I5
MB<\-+.G'UFULIF2?0J61Y>$AC/XJB6:`F;KCZCSL#8*U(S=E<TR<K#ZZLG-=
M=).SI+-BOD3MS&.51+B3O'V:C5]>6W/[,RWD#1PK(8%=]K31ND4\R.DBI&)4
MD$+K.I4$-Z;!@`0VRZAB)E.<YRD(0!,8YS`4A2EZB8QC"!2E`/41Z:\TDD<2
M&65@L:BI)(``'B23T`'Q.D``6(515CKIMI*.>'%-I(,7:@=1(V>-US@'VB1)
M0YM>"TS.(OY/2L;JVFE'E'*CG^16)UVR6UQ$-TL;JOQ*D?SC7=UDM=.C1HT:
M-&C1HT:-&C1HT:-&N0`>GY1VWT:-*WCK)UJR3G;(<;%R";;&^/$@@%&'LT3+
MR]B*)D'RRCLR9ET18O0.!2E,4#$*&X#N.J6]J>\7-^[GN5Y3B</=)#VDXJGT
M1A])"]U?"J3,92"Z>C,'`"L`R*M0>NF9R#C>,X[PFPN+F,MR&_/JAMQHD7BH
M"UH=RT\0:$G549LP'GC.=M5^H6:#JU$9+E;Q4*1\_7*LS`YA/(OFK4545Y(Y
M0`/G`2E'[NP";24]PWMC]RWN0YN[9;+8[#]M[>4);6BSRLK15),\T<>Y7N"`
M!\W1:@+0%M2CAW.>$<*Q8$%O/<YIUJ\FU00U/PJ6H0GW=3Y^6FQQ3BZM8BJ#
M"I5MN0J:`=Z1D#)IE>2T@H`"N]>*D*4RIQ'Y2`._!,"E#8``-7@[)=F.(]B^
M"6W".)Q`)&-\\Y4"6YG;\<LK``L3^%0:[$"H*!0-*WE')LCRO+/E,@QJ>B)7
MY8U'@JCR^)^)J?/2J>:-':J1<++4\BZ&5<HS\/BR)8+P,%9*1;UTV4K9VA<D
MQ5I:/:XTBZM$5Y\Z;2ZB97[`0,DT5(HYXG<*?;X#4K[>Y%Q-)!?T.%LHGN&8
M.\<T0)6,_3M&1(6D9T5H@2C]&=2$J,!?)[R#B:+EVJ^/^6L5>0ELJ&:ZY7J8
M.>,$6?,\JP1.TR-.T^/9LZSF&17BH>*89#C':L6=@W3]RW,FHS$Y#)B/:OQ'
MV_#5G>'\8GR6$FY/A+S%PWV/EDE^CO([13U@24EI+50S.T#*)`Y.U@PDH0=;
M(X,P7!S]RA*Y>K$E9ZC*UN&R;C^7B6;9.8SC6JPY9-V<GF>U.D0NLG,4Z4E6
M2AX=9P,&=RLFNBB)T`,3K8FE1T/\VD%R3DEQ:X^2[QL1AOHYGMYE8G;9R2`E
MEM(P?25)55P)0OK!059J-0ZK.VK9\V<,WB"3IH[14;N6RZ9%45T%BB15)5(X
M&(=,Y3"`@(;"&O!?65IDK.7'Y"))K&>-HY(W4,CHP*LK*:@@@D$$4(TE8I9(
M9%FA8K*I!!!H01U!!^(UG-.^&]^IM^6NN#;BRA&7O@D6D&]<OFJR`]T%#QBJ
MJ'%N\C3;B4`5,8W'U^&M3_)?8)W-X#W-?N%[=,[!C\<+@316DLLT;I1MQMW9
M1LEM^I4+(2=M0W6FK`V7=S!9?!##\TM'FFV;&D4*P/2F\`]5?SZ>?AIDLSV/
M*M7PH-TB5F$-<JN1A-65DB@A(1CMDQ6*:712.J58Q$%4$Q.7B("`&V'TU;3W
M`\K[U\.]O7_$#"RVUAS_``ZPW5_"BI/;RQPL#<HI8/1&4;A0@T8J2"-+WB&/
MXQDN8?E%TKS8BY+1PL25=68?(2!3J#T_175P4"VM;Y2ZS<&)!(WL,.RDRI"`
M@9$SA$IU$C%'J4Q#CMMI]=K^<V7<OM]B.>8\;;;*6,4X4^*EU!93\"IJ-1/.
MXJ7!YBYQ,QJ]O*R5^-#0'].I=J>:Q.C1HT:-&C1HT:-&D<I%X^H>569G=ALH
M1,33H!.K1[1\^1:1H%!9LY,[*@LH4BKHAB]!*`F$!'6MWMYW%_,O>GSZ_P"5
MY<6.$P6+&/@CFF6."GJ1N9`CL`TBE30CYB&-?'3JS.%]#MEB(K"W]6ZNYS,S
M*I9_`C;4#H#_`"=-1>O>.&,LE3]OL%"S)8W;9:R2*MO3@ES))*S,DJ>1<))N
MR@B!`)[G;H4X=.@ZAO%O:5V@[O<FSG*.VG/\M-:296=LFMFQ16NIV:=PLHV`
M`&0BH5_`]=9+(=PN1\=L;2QSF(MUD%N@@,@J1&@V@E>OP^(^[3MT.DQ&/*Q'
M5.#6DG$?&E,";B7>FD)!<Y^/<5<NC$3[AS"7X%``UL7[:=N\'VKX?:\+X[)=
M2XVU!H]S*9IG9OQ,[D+4GX```=`-)G.9F[S^2DREZ(UGD\D7:H`\`!UU,-3W
M6)TO_DK!L7N,W-J/..:W/XUD$[Q2)MLU+(>UN2+%_7X=HO%'6:DEV\W]?4CS
M-A61!070?.7;?7)?&GQU*>(7,D>7%D(UFM;Q/1F0G;6(E78AJ':4V!]U#3;X
M'7\T&?\`-<6ZLM&P=?7ULP-=\JS./92)6)!N[SA&8EJ;EB0MSNG4F]MV;&Q^
M.MFE\IJ2+-^52,MR;:2,JB@*Z:93&]`!IN'6G_P_R]-6]XQQZ9+.XY)C%@R>
M.LHYU8;Q#=JLMLL0EFA),=]&MN$9")+4M&%9MI)IN_X-$@[1!N;BZ0CXBTUJ
MO0U&@,?0YG+BMXMQL?O.H*.JLL\!%[:8^W*1WN59EPW8K2)F9#"S:\!*;H>O
MAJM7<@W-E<BP0L]E-*\SSM027$_0.TBBHC:+=M$2LX3<?XCUJ-`-<-*[7!B@
M8IBCZ&*)1^'0P"`]?Y!UQ=%D0HWX6!!^X]-?02#4>(TCV0O$FG%2LMC5R9<Z
MU5U`DIRRL7;]648D:J"HZDQ('ZLZ34"";8G!3B7IUUKB[J>QO@20Y;EUQS#D
M&(X8PGN[^&25KB$1G=+/0?*5CINHNQR%H/FTZ,!W3R[/;8],;:7.3&R.%E4(
MQ(HJ?&K>%345/PU%LE/Z9$>*J[;%V2T9Q*AO8:4A7:$FFA)G1:RC5JBP4;@5
M%PX(W%T!C!P*`\>OIL,-[LY#M_AO9@^/[.<P3(P\<NK2XM9$N%CN"D=S'&L+
M1T5W$9E!*[5!V]>@H<GQV'+W7<U9>2XXPM>I(DBE"4JR,Q8'J`3M^)\=.SCN
M>5M%%J-@7YBXE*]%.G1E"\3'=G9I`Z4$/@"C@IC!^0=;$.U')IN9]M,%RBZW
M&[O<7;R2%A0F0Q+ZC?\`2<,1]ATFN06*8S-W5@E/3BG=5I^SN-!^@4U,M,'6
M(T:-&C1HTIM\R-/Q?E'BRBMIM2.K$C5)9[+L3@4&TA(F/($:<S&+N8W$A"DZ
M[`?5'^YO=7D^']Y/#>W5IDGM.(7.'GEN8"`(YYF^H$=214GY$"T-`WVZ:>#X
M_87/;3)YJ2$29*.Y18V\U7Y=W\YK]FJXF,+>-N2\U62/?VU_9;Q-N%[3)0T8
MY.,<R:H"U;+,#2$8!&R:B1CE`2'4]P'/2ASOM\]I/=WW#9?%Y'.W66[CY&5\
MC/:V\C>A%&GIQO"9[<"-66JU5Y/7&ZIU(;3F/</CO#K>X@M([?"PJ(4D=?G9
MCN(;:_4@]>H7;TTYE,HE1Q[#D@:;`L(&,*8%#HLT@!1RL!0("[UR?DY>N`3`
M"]Q4QS\0`-]@UL$[?=M."]J\"O&N`8RVQF(!W,L2T:1@*;Y9#625Z`#?(S-0
M`5H!I09C-Y7/W9OLO.\]R>@+'H!\%'@H\Z*`*ZENIUK%:-&C48N=3B[S5IRI
M3)3_`$^;9':J*I;`NT7(<CAC(M1-T(]C'Z*3A$P_=52*/PT`T-=>S'WTV-O8
M[ZW_`*V-J]?`CP93]C*2I^PG7\[/D#AGR<P_E+&F.VN2,6W64:90\<9/!=JN
M$-:E9!J\F/*"7GSK9;,R.`RYUK!(+.#*QXE5`Z@@40``UZ%92*T/G7^35K>+
M<@X?GL+>95[2]MX6L[Y;R.)XPI"X]4I;5_#\BA0'Z=.NMK/%?Q\E\"4V22NE
MT/D/)MQ=M).]VE)F2*A3.&1'(1T%6(1$B*$97(+WRY&H"F5<Y%-U1,(!MTLV
MX_9JO/->4P<FOT./M_I</;J5AC)W/0TW/(YJ6D?:I;K0$=*::'7'4,T:-&OB
MY;-WC=9H\01=-7*1T7#9PD19!=%0!*HDLBH!DU$SE'82B`@(:\UY9VF0M9+&
M_BCGLID*21R*'1T84975@592.A!!!'CKG'))#()86*RJ:@@T((\"".H.D5S1
MXW^,-703M=K*]HK&:DBPH+Q"DBJQ^JR"3A=!06J8KH,$DR-SF$>)$"@7YM:V
M/<'[3/9YPNWCYKS7ZGC>.O[Q;4-:M.T/U4ZR.C>DOJ)"JB-VKM6%:?-04T[.
M']PNY&3<XO&;+V:&,R4D"!MBD`C=T+$U`\2QKTUZ67+P[QG#>.+''UR^H03B
MU,X1RLU.R<IV:$9MXXA47"S8AFX$(F8>7';<1UE>^7<>][0\?[3X[M9G_J^-
MR9F*TD>-HG6_M(EMU"R-&"E`K4.VE2WQ&O/Q7"Q<CN^039ZS].]6V:0!MP,,
MC%^H!ZU)\*_#3NE'<I3?TBE-^<`'_OK8RAW(&^(&DP>A(^W7.N6C5=Y9N;S'
MF.+==8]@23>UV*%^V8*'$B;E3W""`$.<`$0*4%A,.WV:5/?'G^0[6=ILYW!Q
M5NEWD,79^LD3DJKG>B48@$@`,6-`30:S_%L1#G^0VN'N',<-Q+M+#Q`H3_FI
MI5K]CF#\CJCCO,D];$*!'QE466L,FS3[BY$?ZPL]9H.O<MS(H).C'VVYG'T`
MHCTU2;N;VIX[[LN#\5[^\GS<7&,79X1GO;B)=S!07:6-'+IM19"X'XV\0%)-
M-,_!\@O>WV4R'$;*U:^GDN@(D8T!/0*Q%#4E:?`?;J[<`8NQ12JLSL&-SA/)
MV-H5<US>"9:2FF_<.`#WED454FP*%'8@E`0^(CJQWMA[+]E.W?#H>4=IV_,E
MRL6XY26K3W*;CTW,B,D8<-1-H(/B3TU#>=\FY1F,F]AR$>@;=J?3KT2,T^`)
M!-/.NF!V'[!_-JT.H'KC1HUSL/V#^8=&C7&C1I%_(7QBGLMYUQADQI&5:484
MQ*BA'RLW,2$=-XXFJC?GMN=6^J1S6->-+#)RL>Y39]ARLU(EV0.!Q$=M<U:@
MIUTR>*\RML%QJ\P\CS))<&;<J*K).LL(B$4C%@456!:JAB:TIIYR@(%*`F$X
M@4H"<0V$X@``)A#X"80WUPTMSU-1KG1KYKG8?L'\PZ-&C8?L'\VC1J.VFJ5Z
M[0CRN6B*:S,._*!5V3Q,%$Q,'5-5,1ZIK)&ZE,'4!U%.:\(XKW$X[/Q3F5E#
M?X&Y%'BE4$5'X67S5U/56'4'7OQF4O\`#7B9#&2M#=IX,II]X/Q!\QI$Z1XP
M8Q>9"B[-CK)2]@CL=W-)::J$ES>DCG3!T19=F194S<4>SQ`H<4!(?;;ET'6M
M/MW[.NSN1[IV7+NU'+Y,GBN*<@0W>+G!E$#P2*SQ!B4*[:!:B$JU`-]0=.[,
M]R>20X&3'9_'+!/D+,B.=/EWAE(#4%:U\?Q5'C33)8FS`\R/=LNUI2-:(1V/
M;*G"Q4DT6.J$DV-[HO>7`Q"E(H?L`(``B&V^K=]C^^]_W8[A\XXC+:P1XGC&
M5%M;3Q,S>O'NE7<]0`&/IU&WI2OPTN^4\3BX]AL5D5D=KB_MS(Z,*;&Z=!]G
M7SU?>K.:@VJOMDQ2[=(3N%G\DF%DFJFM)J11TS`;Z4X4,@B\*H)13/P=)@(E
M#YM@TE^=Y_M]SK)Y+V]Y.[0<LR.#><VY4U^G=BBRAB-IVR`$J"6H*TU)<59Y
MC%00<P@C/Y=#=!-]?UP*E?B*@^.LZ:5X^Y4G2PN+,BWU"I8VB['-(0M7<R"4
M?-W!M'RSL[QU%Q0F3=NVSDY3K(G6*<A2"!R;=!UJ@[>^UWO/R48_LOW6Y+'@
MNT]GE[M+3'23K!=Y..&YE,LEM;5666.0AI87E5D",'C`&UM6!S'/.,V/K<EP
M%BUWR&2WC,DP4M'`610H=^JJ5Z*P4@D]#K4ZO0$3582,KL$S381$.U39,&:>
M_!%!+T+N.XB(B(B(CZB.MT_%.+X/A7'+/BG&X%ML'80+%#&O@J+]_4DFI)/B
M3JLF0O[K*7DF0OG+W<S%F8^9.E'S,G>J)87<[6;G/O'+E`UL@*XZ625C71J^
MJ+^Q5H4`)S,W>0[8QF^_SF64X`.VP:HI[@H^Y?;7E<_(^(<@RD]U-&<E96,C
MJUO(;)O7OL>4`J4EM8V,%?G,K^FIH`--;B#83-V"661LX$C4^A+*`0X]4;8I
MJ_%7(W^045IIIZK9(V]5&)LD2X.+"PQ*;E%5,>"R(N41(H`?%-=!01Z>H"&K
MJ\)Y;B>YG!+'EF$E;\MRMBLBLIHZ>HE&'[KHU10]01I8Y3'7&#RLN/NE'KP2
MD$'P-#T^\$:6!E4+PAEZ-I'[PKFK&1B:]ND7R[I,_P!3K"R0MXIB;9/L(JDL
M"*K=38`.9`@#ON.XTSL."]R;;OQ:=N#RGD#X:T5\G/,\@/U&.==EM$:+L5EO
M5D@DH`[1(&KN-2RI<KA7XI)FOH+,7,A$"J%_!,#5V\:D&(AAY!C3PTXX!L`!
M]@`&X^H[!MN/Y1UL!`H`/&@THM+KD_*,I3\KXGKK8.->EWJK6TKB4HHE/8#F
MAH%-94?V)D)$H*]!#H(<OEU4WO+WHS/`^^'".*6G3BM]<M'D7H-@-\3:6:NW
MZI2>DG0CH06JNF#QKC-MEN+Y2_D_[?$@,(\_X7\24@>=5Z?S==,7_)U#X#]H
M?`?Y]6SJ#U'AI?:\Z6C_`*K&O(X'CM@+M`Z/O&*G:=M^91#N(*?H*%WW`?MU
MB,]BCG,1<8D7$]J9XRGJPMME2HIN1O)AY'7HM9_I;A+C8LFPUVL*J?L(^&DY
MOE!R##R%MCX?+EN:BG3).[559PX0<%3+7#-DYN*E2B@)CH+C()"W.0`4`2CR
M,(:H#W,[8]U,#E<[B\#SK.PE./W&6QK/(CA18&-;NVN1LJ4<SQF!UHX(.]B*
MZ;F$SN!NK>UGNL5:-6[2WG`!%?5W&-TZ^(V'<#TZ]!KT_%R&MUNQ_5<G6[(E
MFF7LRL[?(1`KII1B#9C(.8\&KE,J93.!649F.81$0XF`-9_V:\;YUS;MIAN[
MW.N5YC(7]]--*EMO"VZ1P7$EN(Y%"@R%FA9B22*,`//7E[EWF*Q6=NN-XK'V
MT,4*JIDH2Y+('J#7I0,`/NTXFK[:4ND)S/@^?JU]0R1A&[1-)N5K54:KU*1E
M&L<WMTH0H&%.):OCE8OG2G,!.B<IPYFY%`#&$1UD>X'VY<EX7W,3NS[>.167
M'N>YMV1L9/<Q0)D[D`$K;1S$132-4%X65@78.H#,Q+RXAS2QR>#/'N96<MYB
M+4`B=$9S`A\W9?F513HP(Z"A-`->YXZ0L=X^XL/9LI/W,#/Y#LK49-.435!P
M1^J=RA$LSI'(#@')D5SF5$W0``1Z``ZD/M1P6)]K?9AN8=Y[F;&<FY3EXA.M
MR&#B9FD2VC*D;Q(59WDKT`JW0`G7C[@7=QSSDPQW&46>QL+=MA0BFT`%V!K2
ME0`/Y/'3F_46'_MM_P"Q?4OVI/\`X_;?WGK_`&?;]/TUL%_-\7_;Q?\`9OJ/
MQ#^H_M?'\'[WA]ND_P#3S_L-^/9X?K?L_?\`9I&/*R#M=!N],\C:4R,^5JS8
M(>VM]C&(>([A@9]\A1W%F87:Q3F#J104QV'X:V_>QQOF_;+N+Q_W6]O(#<S8
M:+Z7))U*FVW?PBX'_5-ZDJ,?U7,1H0.CK[87N+SN%O.W^8?8MRWJ0']^GS4/
M[7RJ1\1N&NE@F#O6;LK*^0.1HY>'@H=FJQQY!J\DTRMUN94UDDC<5#MT2*BH
M*Q@+W7&X@7B(:Q_MKX[W)]Q7>I_<_P!U[62PXU8PM'A+1JJ`C;E5E4@,4579
MS*0/5F)8+MIKNYM>X3AO%QP3`2+->RN&NI!U-1Y$^%32FT5VK05K76@.MHND
M1JJ;[`J6*6CV34R24HA&N)&$<K!NBVF8]55S&K+@`")VQ72914)^F0!#2-[H
M<8EY7G;7'611,S'://:2/U6.Z@9I(&<>)C$BKZB_K+4:E."OEQ]I)/*";8RA
M)`/$QL`'`^!VDT/D=4?@&>3IURG\6N`4:PMB!Q=J&@Y$"F8"=4$;+5U1,/5]
M&.#H*=L/ND4U7/VO<GBX!S_*=F+H-#Q[+!\MAD?H826V9#'L3_UUNYADV#\*
M2$ZF?.K!LOB(.31T:\MZ6]R1^MTK#,/W7`85\R-,@1,G[QW2O`O<_`S!/GM\
MW`+!(F`F_KQY#OJW"11_\7)I]H];^[<*[O.GULYI7X5-=+PL?[NJM?E^M8T_
M_$FIMN`=1$``.HB/0``.HB(CT``#3%)"@LQHH\=8;QZ#QT@>6(J2M$/?+`V<
MK"I=!F']0:`!A/&2N'U%UR*(&$`*4\RM$?JMA^?F&M7G>W"9?F>#Y-RBTED]
M7D/U4V,CH:V]SQ9G=60T`!NVM:QT-'W"GCU>O%KJVQMU8V$BC;9^FL[?MI?T
M!!^R,/\`-\*:<K'EH;72C52TM=NU-P<>]X\@,*:BC<@*IGV]#D.`@(>H#K8'
MVIYG:]PNV^$YI9T]#(XZ&:E:T9D&Y3\"&J"/+2BY!C9,/FKK&2_CAF9?T`]#
M_)J9:8.L/JC<E?YB?_[(93_Q-:U6ON__`.:[O_TYY'_K,?J:\=_W?'_WS9_S
M3:CGA]_QPQE_<9K_`%+,ZCOL5_\`:KQ/_0WO_B-YKW]V/^8.1_IQ_P"ICTRN
MK;:7>EH\G\3R^2J8PDZFLHA>*(_/8JN9)0$U'#A,B9EV2)C&(0KEP#<H)B80
M*!O750/>1V2SO=KM_;9GA#O'W%XW<F^Q^UMK.X`+1*20`[^FGIDD`,.NF-VV
MY1:<>R\EME`&PMZGI35%0!UHQ^P5-:>6D_A+%E;RCR+0*;;8!:$B<7R#67O8
M]HZ2*LQ'["B[<MU"D[*SI8@I$1`Q]B*G$#"`:H3QWE7>WWE]U^+\"YQBY,=A
M>&W4=UF#M*HUS#T621&`V/*P,:1`M\DDC!B!739O;#B_;3C]_E\5.)KG)1E+
M;K4A'\5!'B%!W%J#JH%!K5+VK;_UT_V/M?N!_9?3V_I^S_)Z:W5_0VG]DG]5
MZ?@/ZO\`8_H_9X:K'ZLG[1_%N\?/X_?]ND2+F:2QSEV]8RSZZ3D:-:1-+U&6
MD6#96-(PX"(L%DT&X)BV<F0ZE4W!(Z9?3GUUJ+[@,MVG[Z<D[/>YV9;OMSFB
M;K&W,\,;6XA`_J65$"^G(5ZK)7TY(QX>H*NW^Y]OR#BMER/@RF/-6PV3HC$.
M6K^($FM17R_$"?AKM^,UJG,G97RMD%JX?M<=M6S"HU6%!PL$.@6)]LDU49L.
M0-&HJQJ1%1`A"F`3[#]FLA[/>:<A[Q=[.:=T+&2YA[60118S'6H=Q:H+<1+$
M8H>D49,"+(0BA@9*$].O7W'QEEQOB^,P,BHV>9FGFDH/4.^I;<WXFHY(ZD^&
MGGULETD]1%Y_G2%_^I??]5]0'(_\Q,=_^E-_]>LO#_N6?_3+_FTK&?:K+P$T
MVMM434+-,I!2[U=5,!$WUUF7A;JZ!E.13'MT.M[D"CN!0C1$H!UU2KW/<)SO
M%N20\YX2C+R"WNFR^.9>O^V1"F3L:M6IR=J_K[?!18,5`ZZ9O!<I:7UFV*RA
M'TCQBWF!_LV_J)>G]A(-E?\`[PK75[4&WQE^E(FX1"A%&,]C>*>%!,W($'`S
ML@1ZS$?BHR=E.D;_`,B#JS';#GF([GYNPY[@G5L=D^)6\HH:['^KG66(G]J*
M4/&W[RG4(SN)N,%:S8BZ!$T&1=>OF/33:W_26A'WZ]G+=L94G'%ML;]?VZ#.
M*40%8-^:9Y$Z<<59,I?F.=N+KN;!U'AJ1=].;6/;OM+G.5Y&3T[>"R9-WF&G
M*P!E`ZDH9-]!U.W7BXKBYLSR"UQ\`W.\H-/CM!:A^_;3].E.EO([!:5%I\+'
MW!)]+5=Q5UE><0]#ZD#!9H,^D8ZB':*$T1-0%!WV'GJC>;]V'MNA[;8#C^+S
MJ7.<PLN.=MUK-_M'HM$;U2S(%'U:B0.:T.\Z:=KV_P":MF[N\GM"EK<K,!1U
M^3<&](T!K_#.VGW:M3Q@<GAXR_8S<***+8]N;Q!BHJ)=U:_-<W<,9(``-T2)
MMS@!NN^G7[,[M\#A^3]G[IF:XXMGY4A+$?-97>Z6U*C]@*C@'K748[E1B[N;
M'D<8`2_LU+4\I8_EDK]I)&FCU=+2SU1N2O\`,3__`&0RG_B:UJM?=_\`\UW?
M_ISR/_68_4UX[_N^/_OFS_FFU'/#[_CAC+^XS7^I9G4=]BO_`+5>)_Z&]_\`
M$;S7O[L?\P<C_3C_`-3'IE=6VTN]4!Y/1=CD\+6X]6DI*+EH=%&P%7B7*[1\
MLVAA.\<M$E6QTUA]RF3B)2CN;57/>3A>5YCV^9R3AEW=V>;L(UO0]M(\<K1V
MM99(U:,J_P`ZBA4'J.G74[[;7./MN86JY...6UF)BHX#*#)\H8@@CH?/2MO?
M*^"3P_%+4E%NIG&^HL8"219-&X2"<XTXQXS$J(([+BH*PE:]S<QA4Y!N!3:I
M??>]OC,'8BRF[?)$WN-Y/'#97`AB3UUNXJ0&ZN/D^<MO*VV_YF,FX5"L=,R+
MM??-RR5,P6'"[$M*A9CL]-OF]-.O2E*O3H*4\QJ[?HOD'[#L_B%U[[]P79]Q
M[5CQ_>C^)??<^/8X_4/P]_5=MN'+YMN775BO[O>Z7\K]#\TG_,O^%^W?LAI_
M>+\P]:M-E/7^A_V?PV5^:F[KJ&_5\#]?=Z"^C^>UI5O^Q^CM^/X?5^?X^5::
MY?.L&^7L+.5HIU4YVNN%6C==ZT18V:(.?B;W\:F=0XKL5Q3$#%`P"/'Y@+N`
MCRR-][</?;@<AQ-6=.2XJ5HXWFB2*_MB:?QH%9F+P.5(9=PKM(<)4$_((N:]
MJ+N'(D`V5PH8A6+0R?NN0.C"O0T\^E>NJ]PA-/JGY!S^$JL^1<XXJ-38("@1
M($@-.HQ+1:7ES$2%0@/W\V*O=`QOE`>(".VE=[<\_D.#>Z/)>WGA=RDW:C"8
M6*,H%VUO$MH7N;HA=P$TUX9?4JW0':"=O7/<SLX<KP.#F630KR"ZNF-:U_A%
MV$:=:':L>VG3KX^>GWULXTC=5Q*ST:UR=58!9;C)RD#+N6:/R_K$FA7)UC=3
M`;Y2D'T`=*+-\FQ-GWEPG%YWIE[S&W,D2].JQB0L?&O0`^`.I%:V-Q)QJZOD
M%;>.>,,?@3MI_/KUKY6QM%;>,4!%.2;"61B%R@`JHR#0#&*1,3"4">^;F4;'
M'?\`9K&UG.YW$3S/B$^-MSMRT)$]JX`++/%4@*213UD+P,?V)6\=>3!Y'\LR
M*3OUMV^1QY%6^/\`1-''VJ-*QXVL).`R5?H8A1+4Y"NM;+`-Q*/&&D'MB?-[
M3`(#T*DUB[.D\33+L'(A0.'0P:I7[1<9E^,]WN38&($<)NL5'?V<9!I:32WT
MR9&R0^"QV^16ZC1:"JJL@Z/IG=Q)[>^X[8W;?[TCN&AE/]HJQ*893\6>$QDG
MR)IY:8:TKLYV]TRG&.10\<60O$B@/;53,WBTT8AJS>(F$=R.U9[ND`2B41;[
M_#5JN;75AR;N9Q_@!96>T6?,3I\K*4MPMK%%*I\I6O#(@(()@)\A6`8R.6QP
MEYEP"!)MMD/4&KUD9E/[HCVFA_6^W4^7A(9RBLW7B8Q5%=,Z2J9V+42G34*)
M3%,':]!`=-"ZXWQ^\MI+2YL;1[>5"K*88Z%6%"#\OF-8)+V\C<2)+('4@@[C
MXC].DNI;Q2BY[K+=ZN(HW2M3./9141XI/+;0EVBR4B83"&RCQDZ6#KORV]?@
M.O3M[?R]MO<WA[>_D_V;D.(N\'<L319<GA7C=9R3^M+#)*.M:T`!\BXLQ"N:
MX/<O$/XEG<1W2#S6"Y#`I]RL%^[X:>76R;24U1N2O\Q/_P#9#*?^)K6JU]W_
M`/S7=_\`ISR/_68_4UX[_N^/_OFS_FFU'/#[_CAC+^X37^I9G4=]BO\`[5>)
M_P"AO?\`Q&\U[^['_,')?TX_]3'J>2>9Z?&R,BP`DJ^2AG2K*6DF+9`T>P=-
MN0O$CF<NF[IT+(I1,H*"2I0`.@CIA9CW"\"Q&5N\8%OKF&PF:*YN(8T,$,D=
M?54F22.20Q`$N88Y``"03K"V_#\O<6\<]8D:90R(Q.]@?PGHI`W>6XC57^5N
M1)^H8:0M='E/;#(S-?2"31()P5BI0X&V+SX"";Q$VP@(;[#L(!I.^]CNIR?@
M_8*/FW;F\]$75]:#ZA!7=;S_`#`"M/EE6@((J02#34D[88"QRW+FQ>:BW>G%
M(=A/@Z?YU.HK2<6X+QBRD/(>5-'@TF&;:RPX.FJ!&5;,]1$QVM<:D56%9VZ4
M5X)@'4@"(>FY@@_;SLQ[;>SN-N?=1G&M?H+ZWCO[421H(K$RH6,=C$&;?)(S
M[(Z=5!(Z+5ERN9Y-S7D<R<!M1)ZL3F&2C'=*%-*RM04"@5/Q_P`AFG_ZXQ7]
M+^K]JT>V_`O[P^/TE'O?0OQC^".''WW#WWU?Y^/+M]CKSY?+IB__`.Y>S/Y-
M^>>EFOH_[N?G=/I4W?2?FGY1MIZU/5^I^;;79Z7S>IO^36%_X5<G^I^EK:^I
M];]+^,T]3T/J/V?P[.E?'=TI3KJL\W>*DY)VP,GX1F2U*X&$RTG')NU(]M(N
MN1#%<LURF*BT%8"[+)'W0/Q+L4.NZ>]QGLHY'F.;#O%[=;\83G;$M<0+*8(Y
MY*@B2)P0L6ZE)8VK"]%H@^:LDX9W/LK;%GC?,XOJL3X(Y4,57X,/%J?JL/F'
M7KJ'>/D"]P97<IYRS(VFFM@>2SF+?H"S.9=PF:2!59ZW2(F4BI9"64/P43#M
M=H0$`VU`?:WQO(^V_BO-/<;W\AR,/)Y[Z6WF0Q$NX,X9YD4*`PGN2=KI_#].
MA4!=9;GE[#S2_P`9POB30M8)$'4[N@^2@4FO3:@Z@_-N\>NG]JMFB+E78>TP
M*YG,-.LDI"/7,04CJ-E=P*)DS?,0P"40$!^(:V@<*YA@^?\`%+#F?&Y#+@LE
M;K/"Q4J2C>%5/4$$$$?'2+R>-NL1D)L9?+MNX'*L*UH1]NJ(M6(\BSV0(Z^L
M[;5VCZ`E3.:^*T5*G6:PQT$V[BON12=D168ORE,=8P%!7FJ;B8H;`%9N:]BN
M[')NZ-KW.L<YAH,EB[XR6)>VN&>.T*!'LI-LH5H9@&:5@!)OD?8ZKM`F^,Y7
MQ^QP4F#EM;EH)XMLM'2ADJ2)15:AEZ!16E`*@FNF/:@Z!L@#TS<SP$B>Y,T*
MHFV%;;YQ0(L=14J6_H!C"/Y=6WLOK1:1_F1B-_L'J&(,(R_GL#EF"U\`Q)^)
MTO9?2]1O0W"&O3=0FGVTH*_=JN8.CNX+)%HM#1RB6O6.!CT_IFVRK.?;O%!=
MJMBAL1)D[;`50Y0#<S@YS#U'2DXWVVO^,]W<SS.PFC'%<MC8!]/3YHKU)6]5
MHP.BQ2H%D8`=9VD<]6U(+W-17W';;&RJ?K[>=CO\FB*C:#\64U`_=`'EJFFE
M#S/&Y*89#;-:VZ?.&\U$VHKV1$49"'D'T8ZCD(=)-<AF(0Y6!@3!03"/=-OO
M\*^X_ME[@L/W>MNZEK#B9\E+%=VV1]6<E)K6>:WD@2U4.#$+40-LWDD^HV[=
MTI,)<WP^XX[)@)&N%A5HWAVKU215=7,A(^;U-W6GP%*:9:<6L"4,LM7F3%W.
M`5$4&D@N*3,3F$.\"BQ%$QV3#?;8P;ZN%R2YY3!Q][CBMO;3\CVKLBG<K%4T
MWAF5E/RBM*'K32XLDL'NPE^[K95-645;[*`@^.L_[OX^>15SFJQ.FEZE&/:S
M*/K`@+5VN`+STLZ:NI-V?DX.((+BS(0J8;`4@F#;KK5WW#]K7NLY]R'#\DDO
M<):9##WLU[&8Y'`:]N9(Y+B5JN3L<Q(JH"`J[UI1CI[X;GG`,19W-D(KJ2&Y
MC6([E'2)%*HHZ#J-Q)/F:?#3WQ3BYC4@6F&$2%S3CUMVC5P88AS))D,"`@KW
M1.DW<'`!,'(!+N/4-;+L'==P3P43YZVL1W`2V?\`A1N?II)U!V?-N)5)"`3\
MU5J?#21NDP_YJ4M'E_*#(/F(^<(?'I3J0/#IUTL=XIWDS:W\X\8C0H<)2N.Z
MFS$%G"ZL5"RBB"LOV.;M1)5[(G:)`8YP.4A2CP`N^J<]Q^`^\#F^4R60QQXU
M8"]Q,N-BHSNUO:7#(UULK(RM+.8HPS.&"*#L"DZ8^&RW;G%V\$,WUTIBN%G;
MH`'D0$1UZ`A4W&@%*D]:Z]3Q^H><,35^+HD\6J3-492&[9X@Y43DHF,=K"J^
M01`JY2.0*JHHJ3D4Q^9Q#<0V`,Y[7^VWN.[)<:M.W')UPF0X7#=DI*LC">V@
ME<O,B@.%>CL\B54MN<@DK0#S<[S?#.47TF;L3=0Y-X^JD`H[J**3TJ.@`/4"
M@^-=>19<.9%&S`I!,HUZPCEI8:Q+*R3)!NU3GRF:.OQ-$N@,XEC,X]=4.2/!
M1142CN(`.H[S#L#W9_O?ZG&[>TN,9:27)Q]RT\21QK>@QR?F%M("]R8H7D&Z
M+:[R%&J0"->O'<NX_P#EU+UY$GD">L@1B28OF'HNO1-S!>C5`6HIK[31Z5G"
MC9!\?X5\[>V''L)%^XD?:'0CE)YLDJ#%1H)B?K&R4FB<@D#YBE``WWU[.0-V
M_P#<7VTY1[8N/7$T_)^+8^`//Z92`WL:-Z1CJ.L:W"LI0=0HI6HUPM!F.&9N
MPYU>(B6%_,]$W581$C<&^!*$&OA7KI9<7^+F7\F,:>GE>9?P6-J^BB6.JSAP
MHC(KL&XB0C4L:GP^G*J@7855RBJ"0F`@E$0'5/.S7LS[\]X<;@8^]>0NL;VE
MQB)Z&/D=DG>%*@1BW6GH.U*&29?4$9;85+`Z8_).Y?$N.3W;<7A2?D,Y.^8`
M%`Q_6WG\8_=4TK2H--:+?N?QQV?;_A=CV/P5^[SL[*=K\)>^^I_3>'/CR^I?
MK^[^U[WS\N776U[_`("=I?I_I/R:V^E_N]^1[.NW\M];ZGT*5I7ZC^-ZG]9Z
MOS[MW75?_P"]O(=_J?4OZGUGU5?/U]NS?]VSY=OAMZ4IJ$^0U^R-C6K1]IH5
M<2LJ#*23_$K043KKI10E-R62(D114A`.``8Y"G$FX#QVW$%[[J>YW=?M'PVT
MYGVSQ29:VM[L?7Q;2SK;T/S*%#,!NZ,ZJQ2H.VE2,QP'!<?Y%DI,9G+@V[O'
M_!:H`+_`UH/N!(K\=*9F;RMQSE3`MFB8[W$5;W9H5$]8E4Q%4QQD6X/UF#E`
M%45T61.1RF4%(YBE^Z`]-4<]P7O8[4]ZO;-E\)BQ+8\ZG-HIL+E?F8^O'ZS0
M2)N1UB&YP7,;$`'8#T#3XAVPY!QCG%M=7&V7$IZA]9#T_`=H8&A!;H.FX?;I
MBL!7*MT/!^&HNZSK*OR%BC"LH%I)G425>JBL<Q$$]DS%2V!0O4XE*`F`-]Q`
M-6P]LG<'B';7V[<"P_<')08S)Y:U]*RCN"RM,Q8L%7H0M`PZOM`W`$U(!@'.
ML/D<YS/+W.'@>>"WDW2LE"%%.I/7KX>53T/PTU.KJZ6&CUT:-4!-^1=.0F9.
MLT:%MV7K1"J*)2\-CB,:O46!D!X.2&LL^_@*:Z<,UP%%=!"15<(+D,DH0JA3
M%#EM/GT&I1;<3R#6Z7F2D@L+.0?*\[$%J^'\-%>4`CJ"8PI!!!((.J>EO.VB
M4+VBN<L3YYP*P>JJ)-Y6\8^_%$:(E4*DB=9SB"4R6#1%R81XG6[9"``BH)-?
M=A/X:'6>A[:Y+)[EXY?8S)RJ*E89_3;XF@NEMZD?`5KY5U:A_+#`KV!835.R
M%!9)>39DVU=JN/7S6S6^<DE_E;Q:<`T6]Y#N5%?D.>2!D@V']NHD`"(?-K>>
ML*.$<FCN6M[^UDM(X^LDDX,<2*/%MY%&%.H$>]F_5!U'9CR%NE<^F35JQ2G3
MZJ\6V<1UFN]=9Y+]D<Z1/>Q=/:.'T=-?3@5Y/4F\B=5,!#M%6$=@-M?`]=>R
MWXKCKO?;V5Z9[U1T:.&0V]>O1I2%9-U/D+1@'S*ZD#/RV\?GZITFUY>F%%84
M'*JU%R(U:LE`*4XC(/'531:QZ)2&`PJ+G33`O41VT;&UY)."\IC%7MEZBHI-
M`2?Z($A+'[`"=,!&2D9-1[.6AI%A+Q4B@1U'R<6\;R$<^:JAR3<LWK119LZ0
M4#J4Y#&*/P'7'47FAFMY6@N$:.=#1E8%6!^!!H0?L.N]HUU:B<A?*?$V>(IL
ME88]I:)U-5:)A55#^\>)(%%10Y`*0R2>Q"B(`<Q1,`=-]07+=S>`X/F-CV_R
MV5M8.9Y-&:VM&)]654!+$4!5>@)`=E+4.VM-96WP>7NL;+E[>WD?&P$!Y`/E
M4GP\ZG]`-//68N#\JUS"^:<]N,DNU8H95^[!J44%E'+@[6=E7K5NBB4@@)W+
M)TF)!.)"["`[[#K3O[=.]G$_;][@NYESW8FDLVO+N;TP49I':.[N)41$`\9(
MY$*%BJT(J:&NK(<SXOD.7\/P<?'E$HBC6O4!0&C122?L936E3IE,4>1]VS3E
M%-E3Z4JQQ0P1<C*STLGP>G$J1P;'343*=J5<SL"E%%-538@B(B&VPVW[)^[7
MN)[@^\R8_@?'I+;LI;1R?4WER*2FBD1LK+6,.9:*84=R%)9B*4*[Y1V]PW#^
M-&;+7@?D[L-D:&J^(K4'YJ;:G<0.O0#3I:V%Z3VOR8I3E,0Y2G(<IB'(<`,0
MY#`(&(<H@(&*8!V$!Z"&N+HDJ&*50T;`@@BH(/0@@]"".A!\=?02I#*:,/`Z
M3C+N!_%Z2E",;.M!T"W6@IE8YRQEBQ#MR;<R(+,XIPL:)$!6*(=$/F.`AZZH
M#WV]M/LVRF:7&\ODQW%^=9D%H)(;D6LDAJ5#Q6SN;4_,*=(1N84ZG3<XIS?N
M5;VQGQPFOL5;='#)O4>=&<#?X?O=!J!>;]3CHG#U"EXDHJNJ58XR.BW101$4
M6#EBY<*K&[92E#DYBT!Z``;Z6G^(IP?$X/L1QC.8.KWG'\M!;V\HVDK!+!(S
M,=H`ZR6\)-`!76<[,Y6XNN67UK=](KRW=W7KU96``Z_8[:9BCY;JJ>-<83EP
ML<;"/;;"Q3-L:7=IMCR<R@T10>@B*HEYF5<$,?\`D-JWG;COIPN+M#PWD?/<
MK:X[(YS'6T49N9%C-Q=+&J2[=U*EI`6_Z0TNLUQ7)MR+)66)MY)H;69V.Q2=
MD98E:T^`('Z-7$^:DDH]XR%==!.09.6ONF:O:<HD=MSH^X:K!OVUTRJ<B&#T
M,`#JQRLKJ'0@H14$>!!\#J'QN89EDH"48&A\#0UH1\/CK,+,+;R8\?<4U^BT
M^OL);&:%P=I6*_8C")JUT@JI*S;J2*\M#*R(SL>/UE9Z?\33K=NBHD"BST%$
ME!%37<-C&I\=.3`/Q#E.:ER5_*R9@P`QP7.Z2)Y%0+2,QE&^0`?3PEB#18Z,
M.FJ+E8M.3>?4<?\`GG7<#QLN*IGE?QU<7N;[C..W3-R@$:W89>F\D51^:1=J
MIF%JUBR]4^*?$!$-?1]JUU)(9C#'Z64XS+DYDI1YXA9Q(`0=Q:U2"1=H!^9I
M/.IKI"YWQ%S_`$L'=UQSXPS+>TQ,V[=LO-'`\3?</YS(,PMM9)BQ^+C^:<ML
MJ2\LT5,;E'1"4(=0XBFU*3<NN>Y3T)Z?#R_ETR[;G7%\@5Q^6S,9LGC`.*O6
MANK/Y!_#6/(A`;95/]I*9@!U<GKJPHO*]EIJDXRLWDSX_9IO%K<"#J-\RH*3
M\>/+&%*)T4%F-8C;;+PN-Z,DH14S956(K[%8IU2GY@H1,Q?E/L('V=1K%S86
MTOA')9X?*8_'0#HV*=;[&OXD-(T2O<3']8"6=P0"*4)!G\7Y+9BE\FXZQ[@G
MPUCI;(L:]B&5H85;^(%0LQ0#[%XNRHVM#)56>NYQ`&$Y$"JD@_DDU':(B`%5
M^4-&T4JQZ?=K%S<1P,&'N\KR3/O'BG5S&TF$FM76XI6,V\@"'<C4)2,A3YKU
MUM[X\8XFL88Z)!3Y(EA)2<]-VA2LUPITZI2"3ZZ;LE+J;<RJQ&M=K^PI-TTQ
M!,H"/$``==#&IU77E>6M\SEOJ;4NT*1)'ZDG]9-L%/5E-!61_%B>OQU93R[U
M&/LL=3GMABVUHEFYW4=!JNDRR#MNF)RBJDW$W,Q1,F(!]HAJ$W_<?@N+Y?:\
M!R&4LXN97L9D@LVD43R(*C<J5J02K`?&AIK&Q87*SXZ3+PV\K8R)MKR`':I/
MD3^G6=]">)Y)\YK1*R8G42HZ<XE#%5^X5*(.6%;&,F?8"!VI,X["&X&V'UUJ
MH[:9"/NU_B.Y?-9<L\/'EO5M0W@%M2+2,E3T'RSNP!'1J'QZZ?V<A;CO9:VM
MK:@:\,1DIXU?^(>H^U`/NU>=TPKXX2>6I*<R/.L)&W7F0BR1U4D9PL<4'*3%
ME&MD6+6/69O5U'AFH"/<.?D8P[:L?W`]O7M-R_?&\Y%W8R=M=\XY)<VX@QL]
MX(!O6&&WC6*.!HIG,IC!.]VW,Q`U"L/S'N%;\6CL^/P/'BK)'+SI'OZ%F<EB
MX91MW>0%`--;`5Z#JT6WA:[%,8:*:E`J#)@@1NB7IL)S`0`%54WZ1S")C#ZB
M.KN\7XIQKA6&BX_Q.QML?A811(H4"*/B33JS'S9B6/B2=*^^R%[D[EKS(2O-
M<L>K,23_`/(?`#H->SJ0:\>C1HU0V;/'JDYP;,3SQWD7.Q2)V\58(WB+IL@<
MYU1;+(F,F#IJ"JAC@03EV..^^JS^X?VL=OO<9:6\G)&GLN2V492WO8*&2-"2
MVQT-!)&&8L%++1C6NIQPWGN8X9(ZV(26QE-7B?P)I2H/ZIH`*T/321S_`(*Y
M";HN8YGE.)7KPJ![1*==OV)5E@*<$`7;%1=MDU.NP<3F';?;6NGD_P#AM=U+
M2";&6',K"3BV\&);R2XB#/0[-\866-6K4#:S&A--.6Q[UX&1EGEQDJW]/F,:
MHU!YT-58C[P-6SGG#+T/%:#8S*3(;3BN-0>).(<RJK`R+<Y6\BLDJHBBL8B\
M<7F)A*78X[Z=?N6[`9&/V68W'Y]+<\UX59I*'M2S0E$8+.P8JC%7A&\DJOS]
M3J,<(Y=">YL\UH7_`"S)R%2)*!JD54$`D=&Z4J>FBM>2]MB?&"M9*:5D+7)P
M<VE4+*=T[50!-M'H%[TT<R2;A004,=-,`$-@$VXCKNXC[N^<8+V=8GNS8XC\
MZR^.R*XR_,LC+2.&,$W;%5<_,3''U``+5)\M<<EVZQ5UW)N./2W'TMM-"9X@
MH!J6/2,5(\.I_1IM<6Y)KV7*5&V^"$!:OR'0?L%P(=:/?HB*;QBY)N8!`J@"
M)!'[Z8E-L&^VKR=E.\'&.^/;^SY[Q=B()U*S1-3?;SH=LL3@$^#"J'IN0JU!
M6FE9R;CM_P`5S$F)OOZQ#56'@ZGJK#]'C\#4>6IR6+C"B42QL>42B`E$K)L`
ME$/02B"6X"&FSK!^O-^VW\IUWM_LZ?#ITZ?8'Y-&NK4?F*G5K"BLWGJW!3"#
M@`!9.2BF+P%.)RJ%YBL@<PB!R@/KZAHKKU6]]>VC!K::2-AX;6(_F.OG#UBI
M4]JX&"@H*N-"@JY=*1[!G')@4I`%55=9,B?R@0G43#L`!KJN;F&TMWNKIUCM
MHT+,S$!5514DDT``'4D]`-<Y[R_R,BK<22S2$@`$EC]@`ZZ67'_E,.2<FVNM
MUJJ&=42J0TE*.K<9PJ1=48[C\P-#(]DJ3P>0)%%0%#``CQ``':B/;#WI'NWW
M?S/$N(84S=ML-C[BXDR9=E=O0I0^F5V!93N$2EP[`;MM`:,O.]LO[O<<M<CD
M;K;F[F9$$%!0;_WJUJO3<:4'A7J-4)XNM5LQ^0&1LOV$7#@:ZY.6`(IS,W2,
M[4<L6:(@;<I5&$<V2.4`'H<1';59?9G:3=_/<_ROOMRGU96Q<W^QAJF-3(9(
M84ZU`,$"(P`/1SNIJ<]RI$XEP3'\4L-JBX7^*1XG:`S'[F<D'[.FOU</#S)M
MGR7?;;%7BL5Y2TS\M)D8,I.1*_)$/GI'"9'1$F!3%`3E((EW$O(`ZZ[.>^PS
MO#S'NYR7FV&Y%A<7+F<E<SK#%<7`F%K-,)%$@2$$"NTE:E=P'7PUQQ/=GCF-
MX[8XNYLKF=;:!$W,B;=ZK0TJWW]?&FK@Q)X65*AS<7;K58)*Y66+<H2+$JP>
MVC&$@@J"I%@(95=1_P`%"@)1."8@/7;3Z['?X>_">VW(;/G/-<I=9[EMG-'/
M"&'IV\,Z-N#=6=YJ,`P+[*'K3IJ)\I[PY3-V<F*QD$=ICI5*-3J[*12G@`O3
MQI73KZV'Z3FC1HT:-&C1HU3N;L3$S%3RULMBE*R\:/TI6.D8Q<Z10>((KHII
MODT]E%V@E7$1*4Q#<@`0$-(/W%]CU[]<#'$X\K>8?(07*W$$\#$#U55T`F4=
M7CHY)52K;@"&%-2WAG*3Q++'(&WBN87C*.KBORD@DJ3T#=/$@BE>FD/L_B1G
M!A&.D97-J;BH1[%TK)O9.8FV[!M%E3.=\=^U=22G>:HM^0F*H(E`H;!TUK0Y
ME[&_<9C<//!F^X:R\$M;:1KB6XNKN.!+<*6F,L<DQ#1J@)8.2H4$#IIWXWNG
MPR>Y5[7#E<K(X"*D<98O6B[2$%"32A`K74TPO8,-8FQI<L?VW,%*N$-.+.%T
M"1")A5(#YL=%X!F:SIP9P<JI4CI\=MA)O]FT_P#;_P`K[`=DNT7(.V'.>=\>
MSO'LC(SHMLI+`2QE)08FD<R-N$;)M`H5KUZ'6(Y?8<NY1R*SSN*Q-Y:7<(`.
M\]/E(*_,%``IN!K\=5OX.7-G7\K6^@M)=1U6Y]%\M7BK#VDG"T8NHHB^!(X[
MD=NHQ%,IB^OP]=*;_#C[@6'&.]>=[:6-\\W%,HLSV6_Y5=K=R4FVG\,LENJ@
MCQ\O+4@[T8B6_P",6N<EB"Y&`J):=2`XZK7]E7)(.M4"ST(>2-#$EXTTL0G<
M-&E>("]*3^D+<#]P"_S:W4)RCC<F7/'X[^T;.*NXP"5#*!\2E=W^359#8WHM
MOK#%(+4FF_:=O\OAKUM9T$'J/#7EUTGLC'QJ0+R+YHQ0$X)@J[7303$YOND`
MRAB@)AV]-8[)9?%8>#ZK*W,%M;%@NZ1U1:GP%6(%3\-=T-O<7+[+='=Z5HH)
M-/T:53S-OHU3"<@WBY)-"2MSMK"LQ14`QG4:L(#,=A1,P"&S!3[P#TWU2;_$
M"[FCA?MYNK/$7BQ97.S):Q%&J9(&ZW.Q@?[(^(\*UTS^T.#_`#/F,<ES&6M[
M5#(U1^%Q_5U!_>'AI>?'#(6(*?@Z;JQ[Q!5V]VAC*FE'LTGV4T%GZ"S5DW.?
MNI&=%CTG!^.Q@V$VXZJK[3^ZG8C@?MSR7"WY'C,5W*S-M<?437:[%1I4:.%"
M=RF00J[$4(ZL3X:GW<'`\KRW,X,FME/<82V=-BQFI(4@L1T--Q`KT\M5U0/&
M.^RZ;A_B+.L#+QR3I-.6>UN3DF"2,@=!)10CUHWD!*NH5,Y=A-ON&PAI5=L?
M9[W)SJ39/L1W(QU[B4G`N9;"YGA5)RBL1+&DOSL%84+5W"A&L_G>X^$M2L'*
ML+/%.5)1941B5J0-K%>@J/+3AX(\9I_&5G4NMQR/+W"=.Q79I-0=2/TY,KHR
M)SF<@_<NEG2J7;$"CR`FX[\?35]_;5[/^3]H.8MW"Y]RR_SO(FMGB6/U)O0`
MD*%C)ZSN\K+M(4[@HK7;4`Z4W-^X]AR/&C#8G'Q6ED'#%MJ[OEJ!3:`%!K\"
M?MTX&KY:4VC1HT:-&C1HT:-&C1HUT92,834:_B)5HB^C)1HX82#)P0#H.V;I
M(R+ANL0>ATEDCB40^(#K&9K#8OD6(N<#FX([G#WD#PSQ.*I)%(I1T8>:LI((
M\P==]M<SV=PEW:L4N8G#*P\5934$?:#I4G/@]X_N7"K@82P(=U0RG9:V5^@W
M3Y"(\$D2?*FF&_0`]`U2BZ_PY_;#=7+W/Y=DH][%MJ7TJH*]:*M#M'P`Z#RT
MSX^\_.HT">M`U!2IB4D_>?,Z\W)6'(_$^.W*^`\7,WUZ,'LV]B2*S6L4*S.`
M>YE$I%ZJBZ5=HI[]GM[F*IL.VL)W>[!8SLCVJEG]LO#8+GN.08H[Y1%)?6D3
M#^)<+-,ZR-*H_J]A+*]&IT&O3QWET_*<^J<YR3IA?Q&([A%(P\$*J"H4G\5>
ME.FLS%VEYQQ%R=TL"%A@K]*RZ3."DY,CIO()(&1>*SLLS<+;&)(D5*W2*J7<
M>TL<-PY:T_W%CW&[48FZY]RJ+*XWN9>WZQ6=Q<"6.=4*RM>7$3M0B<,((UD4
MDB.645`;K8Q)L-R"YCQ%@UO/@XHBTB(5*DU41HP'ZE-S%3YJI\M3FP>1.;:1
M)0T#&WR8,VAH>`?D]\K[Q5^K-Q3.?6^J'.81>D*M)&(0##T2*4OPTQ.3^ZOW
M#]O,OC^-XGDV0:SL+&SF7U6]1IFN[:*]?Z@M7U0'N&10WA&%7RUAK'@/#LS;
MRWUS8P^K-+*ORC:%$;M$-@'X31`33]:IU\K++6?(=W4IUEL$[-I6B*/8*PB^
M=.GJE<EW+1Q)IMFA0W651629J("0I?F,H0P@''75R[-\Q[I]PCP3EV3R.0AS
M%DU[CUFDEF:QNI(WN52,=6976-X"BJ`Q>-B!LKKECK;&X'##+8Z"&%K:7TIB
MH51+&&"$MY`@L&J3T`(\],#XK5._3:IJ#ES%[JQXX10>.HQU;XY$P5:1.GR.
MFR+(G*Z%M(".PD3*($.(F^(ZM%[+.#=S.0W+=L^^/#9LMVGC262WERD"_P#\
MZ<BI$(G(D].;P*QCY7)<>)U!.YN5P=G&,YQ7)+;\@+*KK`Y_C+7INV?+5?B3
MU'33)O?"'Q_>NEW0P4ZU%<YCBW8V-^U:I<OT$&Y/D23#X`'0-6^O_P##K]L5
M_>27AQN0A,CEMD5[*D:U\D2A"K\`.@TNH>\O.H8UC]>%MHI5HE)/WGS.KUQQ
MBRDXGAE8*D1(1C)RX!T[.HL=R[>.`2(B"SITI^L6."210W'X!JR/:3LMV[[(
MX!^.=N[+Z2PEE]21F<R2ROM"AI)&^9B%4#KJ%<AY-F>478O<S+ZDRKM4`451
M4F@`Z#J=6'IJZP&C1HT:-&C1HT:-&C1HT:-&C1HT:-&C1HU267<$U3-#ZIK6
M]S(#'599^O\`2V:B:*4J+[VP&0>JF3.L1N!6_7M&3./]+5=.^GMJX5[@<I@K
MKG$UW^5X229_IX65%N#-Z8*2L5+A/X?_`%91JG\0IJ9\5YOE.'P728I8_J+E
M5&]@24VUZJ*TKU\P1]FE1SKXA*6[*E(?4UNK'U>;;LHBT'1)W$*ZQK<<W9M5
MDSGW,`+Q+1)%(%!.918H[B(CJD7N4]B,W.>]?'<AP")[7AN1BAM<@5&Y+&&P
M@CBC<%NOSVT4<48<LSS*26)---#A7==<7QB]AR["3)0LSPUZ&5IG+$4'P=BQ
MI0!3X:8U[XR4$^0*?D>(,^A)NJJ-P50:*%.PE6[=BY9D*LBN151!<#+@8#)F
M(7;<!+U`0MGDO9WVSD[GX#NO@FN<=R#"NFY(V!@N42%XAO1PS(X+`AHV5:`@
MJ:@A?0]R,X,%=\?N@DUG=`T+#YD)8-T((!'3P()\.NF/$1'U'5M=+W7&C1HT
/:-&C1HT:-&C1HT:-?__9
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
